Effects of Acthar on Recovery From Cognitive Relapses in MS

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Multiple Sclerosis
Interventions
DRUG

Adrenocorticotropic Hormone

Acthar Gel will be administered in accordance with the recommendations set forth in the package insert. The dosage may be individualized according to the medical condition of each patient. Frequency and dose of the drug may be determined by considering the severity of the disease and the initial response of the patient.

Trial Locations (1)

14203

University at Buffalo-State University of New York, Department of Neurology, Buffalo General Hospital, Buffalo

All Listed Sponsors
lead

State University of New York at Buffalo

OTHER

NCT02290444 - Effects of Acthar on Recovery From Cognitive Relapses in MS | Biotech Hunter | Biotech Hunter